Clinical Trial Update: A Study of Pentasa in Patients With Ulcerative Colitis

View source ↗

Summary

A clinical trial evaluating Pentasa (mesalamine) for Ulcerative Colitis has completed. The study was sponsored by Ferring Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• PENTASA (MESALAMINE)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Ulcerative Colitis | Status: COMPLETED